Celgene Senior Scientist, Small Molecule Formulation Development in Summit, New Jersey

Description

Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, ​quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.

SENIOR SCIENTIST, SMALL MOLECULE FORMULATION DEVELOPMENT, DRUG PRODUCT DEVELOPMENT

Location: Summit, New Jersey, United States

Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence, and love of challenge. With a presence in more than 70 countries - and growing - we look for talented people to grow our business, advance our science, and contribute to our unique culture.

Description:

  • The successful candidate will be responsible for formulation development activities with emphasis on in-house lab & pilot scale development of the formulation and process for oral and parenteral drug product for small molecule clinical candidates.

  • Member of a team of formulation development scientists and engineers Responsible for formulation design & process development of oral solid dosage forms and parenteral drug products Support the transfer of formulation and process to scale-up and tech transfer groups and to CRO/CMOs Responsible for hands on laboratory and pilot plant work Support regulatory filing activities Apply technical expertise in developing conventional and enabling formulation and process

  • Participate in formulation development project and work in an interdisciplinary team of scientists and engineers. Partner with project leaders to manage budgets, resources and timelines to complete parenteral and oral solid dose projects.

Qualifications:

  • Experienced Ph.D. with a desire to be part of a drug product development team responsible for oral solid dose formulation and parenteral formulation and process development from bench to pilot scale. Solid academic credentials demonstrating independent thinking and problem solving. Good verbal and written communication skills; good problem-solving abilities; and good organizational skills.

Education:

Ph.D. in Pharmaceutics, Chemistry or Material Science with 5+ years’ experience in small molecule drug product development.

Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status.

Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.

#LI-POST

Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.